Tempest Therapeutics Inc. (NASDAQ: TPST)
$0.9244
-0.0612 ( -5.67% ) 689.2K
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Market Data
Open
$0.9244
Previous close
$0.9856
Volume
689.2K
Market cap
$40.26M
Day range
$0.9070 - $0.9850
52 week range
$0.6986 - $6.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jul 03, 2024 |
| 4 | Insider transactions | 1 | Jul 02, 2024 |
| 8-k | 8K-related | 19 | Jun 20, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |
| 8-k | 8K-related | 14 | Jun 14, 2024 |
| 10-q | Quarterly Reports | 56 | May 09, 2024 |
| 8-k | 8K-related | 13 | May 09, 2024 |